Evidence map›Paper›PMID 38921744›Full record

ArticlePathogens (Basel, Switzerland)2024

Clinical Outcome of Patients with

Álvaro Irigoyen-von-Sierakowski, Marta Díaz-Navarro, Andrés Visedo, Mª Jesús Pérez-Granda, Pablo Martín-Rabadán, Patricia Muñoz, María Guembe

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Álvaro Irigoyen-von-SierakowskiDepartment of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Dr. Esquerdo, 46, 28007 Madrid, Spain.ORCID 0000-0002-5137-8818
Marta Díaz-NavarroDepartment of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Dr. Esquerdo, 46, 28007 Madrid, Spain.ORCID 0000-0002-1572-8040
Andrés VisedoDepartment of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Dr. Esquerdo, 46, 28007 Madrid, Spain.
Mª Jesús Pérez-GrandaDepartment of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Dr. Esquerdo, 46, 28007 Madrid, Spain.
Pablo Martín-RabadánDepartment of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Dr. Esquerdo, 46, 28007 Madrid, Spain.
Patricia MuñozDepartment of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Dr. Esquerdo, 46, 28007 Madrid, Spain.ORCID 0000-0001-5706-5583
María GuembeDepartment of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Dr. Esquerdo, 46, 28007 Madrid, Spain.ORCID 0000-0002-7607-5848

Funding

Consejería de Educación, Juventud y Deporte de la Comunidad de Madrid PEJD-2021-TL/BMD-21113Fundación MUTUA Madrileña FMM21/01IiSGM 2022-PI-II-COOPTR-01ISCIII FI22/00022ISCIII MSII/00008ISCIII Pi21/00344
6 · The paper itself

Abstract

background

methodsWe conducted a retrospective study of episodes in which

resultsA total of 89 catheter blood cultures were included, classified as follows: catheter colonization, 33.7%; C-RBSI, 9.0%; and non-C-RBSI, 57.3%. Only 15.7% of the catheters were withdrawn, with no positive catheter-tip cultures. We found no statistically significant differences in catheter type, antibiotic treatment, or clinical outcome among the groups, except for the frequency of catheter lock therapy or in the frequency of successful treatment. Mortality was associated with C-RBSI in only one patient.

conclusion

Indexed as

BacteremiaBlood CultureCatheter-Related InfectionsEscherichia coliEscherichia coli InfectionsAdultAgedAged, 80 and overAnti-Bacterial AgentsFemaleHumansMaleMiddle AgedRetrospective StudiesTreatment OutcomeAnti-Bacterial Agentsbacteremiabiofilmcatheterdifferential time to positivityEscherichia colilock therapyoutcome

Identifiers

PMID38921744
PMCPMC11206651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.